Stress Echocardiography Overview
A mature technique for assessment of known or suspected ischemic heart disease (IHD), myocardial viability, hemodynamic responses, and diastolic function under physiologic or pharmacologic stress.
🩺 Key Clinical Applications
Diagnosis of IHD — Detection of regional wall motion abnormalities (RWMA) during stress in known or suspected coronary artery disease
Risk stratification — Extent and severity of ischemia; wall motion score index (WMSI); transient ischemic LV dilatation
Myocardial viability — Low-dose dobutamine to detect contractile reserve in dysfunctional segments; biphasic response
Diastolic function — E/e′ and TR velocity at rest and with exercise; diagnosis of HFpEF with exertional dyspnea
Hemodynamic assessment — Severity of aortic stenosis and mitral regurgitation under exercise conditions
Preoperative evaluation — DSE before high-risk noncardiac surgery; negative predictive value ~99%
✅ Advantages of Stress Echo
No radiation — Preferred in women (breast tissue sensitivity) and young patients needing serial studies
Higher specificity than nuclear SPECT; superior for left main/multivessel disease detection
Ancillary findings at baseline — valvular disease, cardiomyopathy, pericardial effusion, HOCM identified at resting echo
Diastolic + hemodynamic data simultaneously available during stress testing
Pediatric-friendly — No IV line required for ESE; no radiation; feasible from age ≥6
Limitations: Image quality dependent; expertise required; UEA needed in ~30% of studies
⚠️ Absolute Contraindications — All Modalities ▾
Unstable or complicated acute coronary syndrome
Serious cardiac arrhythmias (sustained VT, complete AV block)
Malignant hypertension (systolic BP >180 mmHg at rest)
Hemodynamically significant LVOT obstruction (for dobutamine)
Symptomatic severe aortic stenosis — exercise stress testing is contraindicated; avoid
Vasodilators: avoid in reactive airway disease or severe hypotension
🔬 Ultrasound Enhancing Agents (UEA) — When to Use
ℹ️
Class I Indication: UEA should be used whenever two or more contiguous segments cannot be adequately visualized, or any coronary artery territory cannot be completely visualized. Segmental visualization is critical for accurate CAD detection.
Definity
Bolus: 0.1 mL IV + saline flush
Infusion: 3–5% dilution
Optison
Bolus: 0.2–0.4 mL IV + saline flush
Infusion: 10% dilution
Lumason
Bolus: 0.5–1.0 mL IV + saline flush
Infusion: 10% dilution
✅
VLMI Imaging (MI <0.2): Very low mechanical index multi-pulse sequences are preferred — prevents microbubble destruction, reduces far-field attenuation, and improves basal segment visualization. Use MI 0.8–1.0 flash impulses (5–15 frames) to clear myocardium if needed.
Stress Testing Protocols
Exercise stress is preferred when the patient can exercise. Pharmacologic stress is used when exercise is not possible, or for specific indications (viability, diastology).
🏃 Treadmill Exercise (Bruce Protocol)
✅Preferred stress modality — If the patient can exercise, this is the test of choice (Class I, LOE A). Provides prognostically important functional capacity data.
| Stage | Grade (%) | Speed (mph) | Time (min) | METs |
|---|---|---|---|---|
| 1 | 10 | 1.7 | 3 | 5 |
| 2 | 12 | 2.5 | 6 | 7 |
| 3 | 14 | 3.4 | 9 | 10 |
| 4 | 16 | 4.2 | 12 | 13 |
| 5 | 18 | 5.0 | 15 | 15 |
| 6 | 20 | 5.5 | 18 | 18 |
| 7 | 22 | 6.0 | 21 | 20 |
⚡Critical: Obtain post-exercise images within 1–2 minutes. Although some centers stop at 85% of age-predicted maximum HR, continuing to symptom limitation increases sensitivity. Failure to achieve ≥80% of the predicted workload for age and sex may reduce sensitivity for ischemia detection.
🚴 Supine Bicycle Protocol
| Stage | Watts | METs | Duration |
|---|---|---|---|
| 1 | 25 | 2.4 | 2 min |
| 2 | 50 | 3.7 | 2 min |
| 3 | 75 | 4.9 | 2 min |
| 4 | 100 | 6.1 | 2 min |
| 5 | 125 | 7.3 | 2 min |
| 6 | 150 | 8.6 | 2 min |
| 7 | 175 | 9.8 | 2 min |
| 8 | 200 | 11.0 | 2 min |
ℹ️Advantages: Imaging during every stage; better for diastolic assessment (E/e′ at HR 100–110 bpm) and coronary flow reserve. Patient pedals at 60 rpm; resistance increases each stage.
💊 Dobutamine Stress Protocol (DSE)
ℹ️Preferred pharmacologic modality for myocardial ischemia when patient cannot exercise, and for myocardial viability assessment. Target HR = 85% of age-predicted maximum.
| Time (min) | 0 | 3 | 6 | 9 | 12 | 15 |
|---|---|---|---|---|---|---|
| Dobutamine (μg/kg/min) | 0 | 5 | 10 | 20 | 30 | 40 |
| + Atropine (if needed) | — | — | — | — | 0.25–0.5 mg q1 min | ↑ to max 1–2 mg total |
| Imaging | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ + Recovery |
Atropine Use
Add when target HR not achieved with dobutamine alone
0.25 mg increments IV q1 min; total dose 1.0–2.0 mg
Consider starting atropine at 20–30 μg/kg/min dose (earlier reduces side effects)
Reduce total dose to 1.0 mg if prior neuropsychiatric symptoms or BMI <24
Termination Criteria
Target HR achieved (85% age-predicted maximum)
Hypotension (significant drop in systolic BP from baseline)
New or worsening wall motion abnormality
Severe hypertension (systolic BP ≥182 mmHg for DSE)
Significant arrhythmias or intolerable symptoms
⚠️Always acquire an additional round of early post-stress imaging in patients with no obvious RWMA during dobutamine stress — some ischemic changes may only appear in recovery (stunning).
🖥️ Image Display — Quad Screen Format
Treadmill ESE
Rest image (1 quadrant) + 3 immediate post-exercise images per view
Obtain images within 1–2 minutes of exercise cessation
Side-by-side display, HR-adjusted loop speed for synchrony
DSE / Bicycle ESE
Rest / Low dose / Pre-peak / Peak stress — 4 stage side-by-side comparison
Multiple cardiac cycles at peak stress improve accuracy
Recovery imaging: all views repeated after peak stress
Standard Views Acquired
Parasternal long axis
Parasternal short axis
Apical 4-chamber
Apical 2-chamber
Apical long axis
Short-axis apex
Image Interpretation
Visual assessment of wall thickening and endocardial excursion is the primary analysis method. Always assess both regional and global LV response to stress.
📊 Wall Motion Scoring System (16-segment model)
1
Normal / Hyperkinetic
Systolic thickening >50%. Normal response to stress.
2
Hypokinetic
Reduced but present thickening (<40%). Reduced contractility.
3
Akinetic / Severely Hypokinetic
Minimal or absent thickening (<10%). No effective contraction.
4
Dyskinetic
Paradoxical systolic motion away from center. Transmural scar.
5
Aneurysmal
Diastolic deformation. Chronic post-infarct remodeling.
ℹ️WMSI Calculation: Sum of individual segment scores ÷ number of segments visualized. WMSI of 1 during stress = normal prognosis (0.9%/year event rate). Intermediate WMSI 1.1–1.7 = 3.1%/year; High WMSI ≥1.7 = 5.2%/year.
🔍 Ischemic Response
New RWMA with stress in a segment with normal wall motion at rest
Worsening function during stress in a segment with resting RWMA
Tardokinesis — delayed onset of contraction (30–100 ms) detectable by trained observer
Post-systolic shortening — continued contraction during isovolumic relaxation
Loss of hyperkinesis — absence of expected augmentation with dobutamine; may indicate obstruction or microvascular disease
⚠️Early RWMA (low dose/low HR) = severe stenosis, little perfusion reserve. Biphasic response = hibernating myocardium (improves at low dose, worsens at peak).
🫀 Global LV Response by Modality
| Modality | Normal EDV | Normal ESV | Normal EF | Ischemic EF |
|---|---|---|---|---|
| Treadmill | ↑ modest | ↓ | ↑ | ↓ (LM/multivessel) |
| Bicycle | ↑ small | ↓ modest | ↑ modest | ↓ (LM/multivessel) |
| Dobutamine | ↓ | ↓↓ marked | ↑↑ marked | ↓ infrequent |
| Vasodilator | ↓ | ↓ | ↑ | ↓ infrequent |
🚨High-risk finding: Stress-induced ↓ EF or ↑ ESV suggests left main or multivessel disease — more common with exercise than dobutamine. Transient ischemic LV dilatation (rest-to-stress ratio >1.7) = high-risk marker.
📉 ECG Response & Clinical Response to Stress
ECG Findings During Stress
ST depression ≥1 mm (horizontal or downsloping) — marker of subendocardial ischemia; recorded in report but does NOT define a positive stress echo (wall motion is primary)
ST elevation — rare; indicates transmural ischemia or vasospasm; usually associated with RWMA; terminate test
Ventricular arrhythmias — isolated PVCs common and benign; sustained VT or VF = terminate immediately
Atrial fibrillation — may develop during DSE (reported incidence ~1%); usually reverts after stopping infusion; may require pharmacologic conversion
LBBB during exercise — rate-dependent LBBB; does not by itself indicate ischemia; wall motion assessment still interpretable
HR and BP response — record at every stage; max HR × systolic BP product (double product) reflects peak myocardial oxygen demand; failure to achieve ≥80% predicted max HR reduces sensitivity
Clinical Response During Stress
Typical angina at low workload / low HR — high-risk feature; suggests severe or proximal stenosis; correlates with early ischemic RWMA
Hypotension with exercise — systolic BP drop >10 mmHg from baseline; indicates severe LV dysfunction or multivessel disease; terminate test
Exertional dyspnea — may reflect ischemia, elevated filling pressures (E/e′), or exercise-induced MR; assess diastolic parameters and PASP concurrently
Hypertensive response — systolic BP ≥220 mmHg (exercise) or ≥182 mmHg (DSE); does NOT make a positive RWMA a false positive; manage as true positive
Exercise capacity — METs achieved is an independent prognostic marker; failure to reach ≥80% of age-predicted workload reduces test sensitivity; record in report
Heart rate recovery — rapid post-exercise HR decline is prognostically favorable and does NOT diminish the utility of ESE for RWMA detection
📋 Reporting Requirements
Required Elements
Baseline RWMA — number, location, severity; LVEF estimate
Stress RWMA — number, location, severity per stage; stress EF and ESV response
Protocol used; peak dose or workload; max HR achieved; BP response
Adequacy of stress; reasons for termination; ECG findings; arrhythmias; symptoms
UEA use: agent name and dose; adequacy of imaging
Overall interpretation: Normal / Ischemia / Fixed RWMA / Combination
For Dyspnea Evaluation
E/e′ ratio at rest and with stress (average >14 or septal >15 = elevated filling pressure)
Peak TR velocity at rest and with stress
LA volume index if resting TTE not performed
Mitral regurgitation by color Doppler at rest and peak exercise
Pulmonary artery systolic pressure at rest and with exercise
Diastolic Stress Echocardiography
Up to 50% of patients with HFpEF have normal LV filling pressures at rest that rise with exercise. Diastolic stress testing is the primary noninvasive method to unmask occult HFpEF.
📌 Indications
Grade 1 diastolic dysfunction at rest with exertional dyspnea — delayed LV relaxation + normal LAP at rest
Indeterminate LAP at rest in a symptomatic patient — stress testing to resolve uncertainty
NOT indicated if LAP is clearly elevated at rest (Grade 2 or 3) — cardiac etiology of dyspnea already established
NOT indicated if diastolic function is completely normal — very unlikely to develop elevated filling pressures with exercise
ℹ️LARS (LA reservoir strain) ≤18% at rest identifies patients most likely to develop increased filling pressures with exercise — useful to select candidates for diastolic stress testing.
🏃 Preferred Stress Modality
Supine bicycle exercise — Preferred: allows continuous imaging during multiple stages of exercise including diastolic parameters at each stage
Treadmill exercise — Acceptable; Doppler obtained 1–2 min post-exercise when E and A are separated
Dobutamine strongly discouraged for diastolic function assessment — not physiologic; sympathomimetic effects confound diastolic parameters
⚡Timing tip: Measure diastolic parameters at HR 100–110 bpm during bicycle exercise to avoid E/A fusion. After treadmill, acquire TR velocity first (persists for minutes), then mitral inflow and annular velocities once E and A separate.
🔬 Parameters to Measure — Rest and Stress
Primary Parameters
Mitral inflow E and A velocities (when not fused)
Mitral annular e′ velocities — septal and lateral
Average E/e′ ratio (or septal E/e′)
Peak TR velocity (or estimate of PASP)
Supplemental Parameters
Pulmonary vein S/D velocities (if obtainable)
LA volume index (if resting TTE not recent)
Mitral deceleration time
Lung B-lines by lung scanning (pulmonary edema marker)
Normal Response
e′ increases ~3–5 cm/s on average with exercise in normal subjects
Average E/e′ remains 6–8 at rest and with exercise; rarely exceeds 10
With diastolic dysfunction: e′ does not increase proportionally; E/e′ rises with exercise
📐 Interpretation Algorithm — Diastolic Stress Echo
1
Assess Average E/e′ with Exercise
Measure average (septal + lateral)/2 e′ at peak exercise or at HR 100–110 bpm. If only septal is obtained, use septal E/e′.
↓
2
Assess Peak TR Velocity with Exercise
Acquire TR velocity during or immediately post-exercise — elevated filling pressure causes passive increase in PASP. TR velocity persists for several minutes post-exercise.
↓
3
Apply Decision Thresholds
Use the following cutoffs to classify the result:
🚨 Definitely Abnormal
Average E/e′ ≥14
AND
Peak TR velocity >3.2 m/s
AND
Peak TR velocity >3.2 m/s
→ Elevated LV filling pressure confirmed; HFpEF diagnosis supported
⚠️ Likely Abnormal
E/e′ >14
AND
TR velocity 2.8–3.2 m/s
AND
TR velocity 2.8–3.2 m/s
→ HFpEF diagnosis probable; consider invasive testing if uncertain
✅ Normal
Average E/e′ <10
AND
TR velocity <2.8 m/s
AND
TR velocity <2.8 m/s
→ Normal filling pressures; non-cardiac cause of dyspnea
🚨Isolated TR elevation caution: Normal subjects can have significant increases in peak TR velocity with exercise related to increased pulmonary blood flow. Do NOT diagnose HFpEF based on elevated exercise TR alone without a concurrent E/e′ >14.
⚠️PASP >50 mmHg or TR velocity >3.2 m/s with exercise portends worse outcomes — independent of ischemia findings.
🔄 Diastolic Exercise Echo in the HFpEF Diagnostic Algorithm
Step 1 — Clinical evaluation: History, exam, CXR, natriuretic peptides, 12-lead ECG
Step 2 — Resting echo with LAP algorithm (Fig 3, Nagueh 2025): Grade diastolic function; estimate mean LAP at rest
If LAP elevated at rest (Grade 2 or 3): Supports HFpEF in the appropriate clinical context — however, valvular disease, noncardiac PH, significant CAD, infiltrative cardiomyopathy/HCM, and pericardial constriction must first be excluded before diagnosing HFpEF
If LAP normal at rest (Grade 1 or indeterminate) with exertional dyspnea: Proceed to diastolic exercise echocardiography
If diastolic stress test positive: Supports HFpEF diagnosis in the appropriate clinical context
If diastolic stress test negative: Non-cardiac cause of dyspnea; consider pulmonary, anemia, musculoskeletal causes
If diastolic stress test inconclusive: Right heart catheterization with exercise hemodynamics — gold standard (PCWP ≥25 mmHg with exercise = HFpEF)
Hemodynamic Stress Testing — Valvular Heart Disease
Exercise stress echocardiography is essential for unmasking hemodynamic changes in valvular disease that are not apparent at rest, particularly in asymptomatic or minimally symptomatic patients.
🫀 Aortic Stenosis — Hemodynamic Stress Testing
ℹ️Clinical role: Diastolic dysfunction and elevated LV filling pressures predict worse outcomes in moderate and severe AS. Improvement of diastolic dysfunction after valve replacement is associated with lower adverse event rates.
Key Indications
Asymptomatic severe AS — assess hemodynamic response and symptom provocation with exercise
Discordant AS grading (low-flow, low-gradient) — dobutamine used to assess true severity and flow reserve
Moderate AS with preserved EF — evaluate for elevated filling pressures that may contribute to dyspnea
Contraindication: Symptomatic severe AS — exercise stress testing is dangerous and should NOT be performed
Assessment of Diastolic Function in AS
Apply standard diastolic function algorithm (Nagueh 2025 Fig 3) at rest and during exercise
In AS without moderate/severe MAC: standard guidelines apply without major modification
Moderate or severe MAC co-existing: use MAC-specific algorithm (E/A → IVRT pathway)
Include in all AS reports: diastolic function grade and filling pressure estimate
Dobutamine Stress Echo — Low-Flow, Low-Gradient AS Protocol
Protocol
Start dobutamine 5 μg/kg/min; increase in 5 μg/kg/min increments
Continue until mean gradient increases, AVA normalizes, target HR, or symptoms
Maximum dose typically 20 μg/kg/min (do NOT use high doses or atropine)
Measure AVA and mean gradient at each stage
Interpretation
True severe AS: AVA remains <1.0 cm² as gradient increases (mean gradient ↑ ≥40 mmHg)
Pseudosevere AS: AVA increases to >1.0 cm² with dobutamine; gradient does not reach severe threshold
No flow reserve: Cardiac output does not increase with dobutamine — high surgical risk; medical optimization first
⚡Exercise hemodynamics in moderate AS: An exercise-induced rise in mean gradient >20 mmHg or new symptoms with exercise identifies patients who may benefit from earlier intervention, even with moderate stenosis at rest.
🩺 Mitral Regurgitation — Hemodynamic Stress Testing
ℹ️Clinical role: Exercise stress echo unmasks ischemic MR, evaluates hemodynamic consequences of MR severity under physiologic conditions, and identifies patients with occult LV dysfunction or pulmonary hypertension that triggers symptoms only with exertion.
Key Indications
Asymptomatic severe primary MR — provoke symptoms, assess exercise tolerance and PASP
Discordance between MR severity and symptoms — exercise may increase regurgitant volume
Ischemic MR evaluation — dynamic changes in MR severity with heart rate and loading conditions
Post-TEER (MitraClip) assessment — residual MR and hemodynamics under exercise conditions
Diastolic Function Assessment in MR
E/e′ ratio: Useful only in patients with MR + depressed EF; direct correlation with LAP and outcomes
E/e′ NOT useful in primary MR with preserved EF — high E velocity due to MR itself inflates the ratio
Ar-A duration >30 ms — reliable indicator of elevated LVEDP in MR regardless of EF
IVRT/TE-e′ ratio <5.6 — correlates with mean PCWP in MR; applicable regardless of EF
LARS not reliable in significant MR — cannot detect changes in "v" pressure after TEER
Exercise Protocol for MR Hemodynamic Assessment
Parameters at Rest and Peak Exercise
Quantify MR by EROA and regurgitant volume at rest and with exercise (color Doppler + PISA if feasible)
Peak TR velocity / estimated PASP at each stage
LV size and function (volumes, EF) — exercise-induced wall motion abnormalities if ischemic MR
Mitral inflow E velocity and E/A ratio (when interpretable)
High-Risk Exercise Findings in MR
PASP >60 mmHg with exercise — associated with severe symptoms and worse post-operative outcomes
Exercise-induced ↑ MR severity — even if moderate at rest, may be functionally severe with exercise
Failure of EF to increase by ≥4% — suggests early LV dysfunction despite preserved resting EF; may indicate earlier intervention
⚡Ischemic MR: Exercise-induced EROA increase ≥13 mm² independently predicts HF hospitalization and cardiac death. A dynamic increase in MR severity with exercise identifies a high-risk subgroup that may benefit from revascularization ± mitral intervention.
🔄 Hemodynamic Variables Summary — Rest vs. Exercise
| Parameter | Modality | Resting Measurement | Exercise Threshold (Abnormal) | Clinical Significance |
|---|---|---|---|---|
| Mean AS gradient | Exercise echo | Varies with flow | ↑ >20 mmHg from rest | Unmasked severe AS; earlier intervention |
| AVA (dobutamine) | Low-dose DSE | <1.0 cm² | Remains <1.0 cm² → true severe | Guides intervention in low-flow AS |
| PASP (MR/AS) | ESE/DSE | Varies | >60 mmHg | High-risk; earlier intervention considered |
| Exercise EROA (MR) | ESE | <20 mm² (moderate) | ↑ ≥13 mm² from rest | Predicts HF hospitalization and death |
| Average E/e′ | ESE | Variable | ≥14 with exercise | Elevated filling pressure; HFpEF |
| Peak TR velocity | ESE | <2.8 m/s | >3.2 m/s | Elevated filling pressure; worse prognosis |
Myocardial Viability Assessment
Low-dose dobutamine stress echocardiography detects contractile reserve in dysfunctional but viable myocardium, guiding revascularization decisions in ischemic LV dysfunction.
💡 Pathophysiology
Myocardial stunning — normal perfusion but reduced function; reversible; dobutamine shows contractile reserve
Myocardial hibernation — chronically reduced perfusion and function; protected adaptation; shows contractile reserve at low dose then worsens at high dose (biphasic)
Transmural infarction — no contractile reserve; no response to dobutamine at any dose; wall thickness <5–6 mm with echogenicity
Nontransmural infarction — partial viability; variable response; may improve at low dose only
⚡Hibernating myocardium is vulnerable to permanent injury — timely revascularization before degradation of contractile proteins is essential.
🔬 Low-Dose DSE Protocol for Viability
Start at 2.5–5 μg/kg/min; increase in 2.5–5 μg/kg/min increments
Image at minimum two low-dose stages (2.5, 5, 7.5, 10 μg/kg/min)
Continuous echocardiographic monitoring — watch for subtle, transient improvements
Continue to high dose (up to 40 μg/kg/min) if biphasic response assessment needed for ischemia
Beta-blockers: do NOT need to be stopped; higher dose (15–20 μg/kg/min) may be needed to elicit response
Can be performed at bedside in ICU patients with severe LV dysfunction
📊 Biphasic Response Patterns
✅ Hibernation (Biphasic)
Low dose → Improves ↑
High dose → Worsens ↓
Highest PPV for functional recovery after revascularization. Revascularize promptly.
ℹ️ Sustained Improvement
Low dose → Improves ↑
High dose → Continues ↑
Less likely to have functional recovery than biphasic. Suggests remodeling or limited nontransmural infarction.
🚨 No Response / Worsens Early
Low dose → No change or ↓
High dose → No change or ↓
Extensive nontransmural or transmural infarction. Worsening at low dose ≤10 μg/kg/min = severely reduced perfusion reserve; high cardiac mortality.
📋 Diagnostic Accuracy & Clinical Thresholds
DSE Accuracy for Viability
Sensitivity 75–80%
Specificity 80–85%
Contractile reserve in ≥4–5 dysfunctional segments predicts ≥5% improvement in EF and improved outcomes with revascularization
Low-dose WMSI and EF response provide incremental value beyond segment-based viability counting
Fibrosis >50% of myocardial thickness markedly reduces contractile reserve response to dobutamine
Comparison with Other Modalities
| Modality | Sensitivity | Specificity |
|---|---|---|
| FDG PET | Highest | Lower |
| SPECT (Thallium) | High | Moderate |
| CMR (late Gad) | High | Moderate |
| Low-dose DSE | Moderate (75–80%) | High (80–85%) |
ℹ️DSE has higher specificity for predicting functional recovery than perfusion imaging. PET/SPECT measure perfusion/metabolism; DSE directly tests contractile reserve.
Risk Stratification
A normal stress echocardiogram carries a benign prognosis (0.9%/year event rate), approaching that of a normal age-matched population. Ischemia extent and severity drive risk stratification.
📈 Risk by WMSI (Peak Stress)
1.0
Normal
0.9%/year cardiac event rate — benign prognosis
1.1–1.7
Intermediate
3.1%/year — consider further evaluation or management intensification
≥1.7
High Risk
5.2%/year — extensive, severe ischemia; consider catheterization
🔴
Transient Ischemic LV Dilatation (TID)
LV end-systolic volume ratio rest-to-stress >1.7 suggests extensive multivessel disease; 19.7%/year vs 2.9%/year without TID. In practice, TID is usually assessed visually by comparing rest and stress images side-by-side rather than by formal volume measurement.
⚡ High-Risk Features on Stress Echo
RWMA in >1 coronary artery distribution — multivessel or left main disease
Transient ischemic LV dilatation (TID) — LV ESV ratio rest-to-stress >1.7; in practice usually assessed visually side-by-side; suggests extensive jeopardized myocardium
Stress-induced EF decrease — global LV dysfunction pattern; left main or multivessel CAD
RWMA at low HR or workload — severe stenosis, minimal flow reserve
Abnormal RV wall motion — RV WMSI >2 → event rates up to 11.4%; incremental prognostic value
Stress E/e′ >14 + TR >3.2 m/s — elevated filling pressures; HFpEF; worse outcome than isolated ischemia
Hypertensive BP response — same management as true positive; NOT a false positive by definition
🫁 Stress Echo in Dyspnea — Special Considerations
🚨Patients with exertional dyspnea have >2-fold higher incidence of MI, cardiac death, and non-cardiac death compared to chest pain patients. Ischemia is also more commonly found in dyspneic patients (43% vs 19%).
Ischemia assessment — RWMA at rest and with stress; EF response; wall motion score index
Diastolic function — E/e′ at peak stress; associated with long-term mortality, CV events, and HF hospitalization even without ischemia
PASP at rest and exercise — exercise-induced pulmonary hypertension identifies an additional high-risk group
Valvular disease — significant MR or AR may explain dyspnea and become apparent only during exercise
DSE in Dyspnea Patients Unable to Exercise
EF, resting RWMA, and failure to achieve target HR independently predict all-cause mortality
Abnormal exercise LVESV response associated with increased mortality
LA volume (marker of chronic elevated LAP) independently predicts outcomes at time of stress testing
ESE/DSE are Class I recommendations for evaluation of exertional dyspnea
Special Populations
Several patient groups require modified protocols, interpretation approaches, or have specific stress echocardiographic considerations beyond the standard ischemia assessment.
⚡ Left Bundle Branch Block (LBBB)
Stress echocardiography has higher specificity than SPECT in LBBB — SPECT produces false-positive reversible septal perfusion defects due to rate-dependent dyssynchrony, not ischemia
ESE or DSE both appropriate (Class I, LOE B); ESE preferred if the patient can exercise
Resting echo simultaneously identifies co-existing hypertensive heart disease, valvular disease, or cardiomyopathy — a unique advantage over nuclear imaging
Septal e′ velocity is artifactually reduced by LBBB dyssynchrony — use lateral E/e′ rather than average or septal E/e′ for diastolic assessment
Prognostic Data
Normal stress echo with LBBB
Event rate 0.92%/year — similar to LBBB patients without ischemia
Abnormal stress echo with LBBB
Mortality 4.4%/year · MACE 3.6%/year · 5-year survival 77% vs 92%
☢️ Radiation-Induced Coronary Artery Disease
Radiation-induced cardiovascular disease affects ostial coronary arteries in a multivessel distribution — a pattern distinct from typical atherosclerotic CAD
Multivessel or "balanced" ischemia causes false-negative nuclear SPECT — relative perfusion defects cancel out when all territories are equally affected
Stress echocardiography: ischemia subtending multiple large territories produces large, visible RWMA readily detectable by wall motion analysis
Serial screening with ESE is appropriate for long-term Hodgkin lymphoma and other thoracic radiation survivors — especially those with concurrent cardiovascular risk factors
ℹ️Clinical context: Radiation-induced CAD may present decades after treatment. ESE is preferred over SPECT in this population precisely because the multivessel distribution that limits SPECT accuracy is the pattern most likely to be seen.
⚡Also consider radiation-induced valvular disease (aortic and mitral) and pericardial constriction — resting echo at time of stress study provides a complete cardiac evaluation.
👧 Pediatric Stress Echocardiography
Why ESE is Ideal in Children
No IV line, no sedation, no radiation — appropriate from age ≥6 years
Treadmill ESE feasible in children who can cooperate; DSE or supine bicycle preferred at many centers due to rapid post-exercise HR recovery and extensive collateral circulation in children
Collaboration between adult stress echo experts and pediatric non-invasive imagers improves program quality
Key Indications in Children
Cardiac transplantation — vasculopathy screening; negative ESE allows extension of angiographic interval to 2 years, reducing cumulative radiation
Kawasaki disease — coronary aneurysm surveillance; WMSI ≥1.25 predicts 25% 15-year event-free survival vs 92% if WMSI <1.25
Anomalous coronary artery (AOCA) — pre-operative diagnosis and post-operative follow-up after unroofing; Class IIa, LOE B
Familial hypercholesterolemia — serial assessment in homozygous FH with LDL >400 mg/dL and premature atherosclerosis
Post-arterial switch operation (d-TGA) — coronary re-implantation complications; coronary stenosis or impingement occurs in ~5%
Chest radiation survivors — anthracycline-treated childhood cancer survivors at risk for premature CAD
🏥 Preoperative Risk Stratification
When to Use DSE Preoperatively
DSE recommended before high-risk surgery in patients with >2 clinical risk factors and poor functional capacity (<4 METs) — Class I, LOE B
DSE may be considered before high- or intermediate-risk surgery in patients with suspected cardiac symptoms and poor functional capacity — Class I, LOE B
Most validated in major vascular surgery (aortic aneurysm repair, peripheral vascular surgery); also useful for non-vascular high-risk procedures
HR at which ischemia develops during DSE provides graded perioperative risk stratification — early onset = most severe risk
Diagnostic Performance
Negative DSE
Negative predictive value ~99% (range 93–100%) — benign perioperative prognosis
Positive DSE
Positive predictive value ~13% (range 7–42%) — but prognostically significant; manage as high risk
Extensive ischemia (≥3 segments)
RWMA in ≥3 segments at high dose + prior MI = independent predictor of late cardiac events post-vascular surgery
🔬 Microvascular Disease & False-Positive Results
Microvascular dysfunction — abnormal coronary flow reserve and stress RWMA in the absence of obstructive epicardial CAD; associated with amyloidosis deposits in intramyocardial vessels
Apical ballooning syndrome (Takotsubo) — atypical and mid-LV RWMA pattern; coronary microvascular dysfunction highly prevalent in this population
Endothelial dysfunction / vasospasm / small-vessel CAD — consider when RWMA pattern is atypical or mid-cavity in distribution
Clinical implication: Outcomes of patients with false-positive stress echocardiograms are similar to those with true-positive results — require intensive risk factor management and close follow-up regardless
Equivocal Findings — Approach
Hypertensive BP response — does NOT make a positive RWMA finding a false positive; manage as truly positive
Basal inferolateral wall motion in mitral prolapse — recognize this as potential non-ischemic cause; note in report
Dyssynchronous septal motion with RV pacing or LBBB — assess wall thickening carefully rather than endocardial excursion alone
Diaphragmatic elevation (pseudodyskinesis of inferolateral wall) — use UEA and multiple views to distinguish